Quarterly report pursuant to Section 13 or 15(d)

Research and Development (Details Narrative)

v3.24.1.1.u2
Research and Development (Details Narrative) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Research and development expense $ 47,000 $ 54,000  
Interest and financing expense 76,000 94,000  
Accounts payable - licensing agreement 2,256,000   $ 2,198,000
Revenues 0 0  
License Agreements [Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Revenues 0 0  
A O T Prototys [Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Research and development expense 1,000 5,000  
Temple University License Agreements [Member]      
Research and Development Arrangement, Contract to Perform for Others [Line Items]      
Research and development expense 58,000 59,000  
Interest and financing expense 12,000 $ 12,000  
Accounts payable - licensing agreement $ 2,256,000   $ 2,198,000
Temple licensing agreement terms With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,121,000 are deemed past due.